-
1
-
-
77953384917
-
Redox regulation in cancer: A double-edged sword with therapeutic potential
-
doi:10.4161/oxim.3.1.10095
-
Acharya A, Das I, Chandhok D & Saha T 2010 Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxidative Medicine and Cellular Longevity 3 23-34. (doi:10.4161/oxim.3.1.10095)
-
(2010)
Oxidative Medicine and Cellular Longevity
, vol.3
, pp. 23-34
-
-
Acharya, A.1
Das, I.2
Chandhok, D.3
Saha, T.4
-
2
-
-
3142514196
-
Oxidative stress in neurodegeneration: Cause or consequence?
-
doi:10.1038/nrn1434
-
Andersen JK 2004 Oxidative stress in neurodegeneration: cause or consequence? Nature Medicine 10 S18-S25. (doi:10.1038/nrn1434)
-
(2004)
Nature Medicine
, vol.10
-
-
Andersen, J.K.1
-
3
-
-
18644386793
-
Quantitative and immunohistochemical evaluation of PCNA, androgen receptors, apoptosis, and glutathione-S-transferase P1 on preneoplastic changes induced by cadmium and zinc chloride in the rat ventral prostate
-
doi:10.1002/pros.20192
-
Arriazu R, Pozuelo JM, Martín R, Rodríguez R & Santamaría L 2005 Quantitative and immunohistochemical evaluation of PCNA, androgen receptors, apoptosis, and glutathione-S-transferase P1 on preneoplastic changes induced by cadmium and zinc chloride in the rat ventral prostate. Prostate 63 347-357. (doi:10.1002/pros.20192)
-
(2005)
Prostate
, vol.63
, pp. 347-357
-
-
Arriazu, R.1
Pozuelo, J.M.2
Martín, R.3
Rodríguez, R.4
Santamaría, L.5
-
4
-
-
78650201244
-
Androgen action in prostate cancer
-
doi:10.1007/s12672-010-0044-4
-
Basu S & Tindall DJ 2010 Androgen action in prostate cancer. Hormones & Cancer 1 223-228. (doi:10.1007/s12672-010-0044-4)
-
(2010)
Hormones & Cancer
, vol.1
, pp. 223-228
-
-
Basu, S.1
Tindall, D.J.2
-
5
-
-
26444463852
-
Molecular alterations in primary prostate cancer after androgen ablation therapy
-
doi:10.1158/1078-0432.CCR-05-0585
-
Best CJ, Gillespie JW, Yi Y, Chandramouli GV, Perlmutter MA, Gathright Y, Erickson HS, Georgevich L, Tangrea MA, Duray PH et al. 2005 Molecular alterations in primary prostate cancer after androgen ablation therapy. Clinical Cancer Research 11 6823-6834. (doi:10.1158/1078-0432.CCR-05-0585)
-
(2005)
Clinical Cancer Research
, vol.11
, pp. 6823-6834
-
-
Best, C.J.1
Gillespie, J.W.2
Yi, Y.3
Chandramouli, G.V.4
Perlmutter, M.A.5
Gathright, Y.6
Erickson, H.S.7
Georgevich, L.8
Tangrea, M.A.9
Duray, P.H.10
-
6
-
-
79957443342
-
Abiraterone and increased survival in metastatic prostate cancer
-
doi:10.1056/NEJMoa1014618
-
de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB Jr, Saad F et al. 2011 Abiraterone and increased survival in metastatic prostate cancer. New England Journal of Medicine 364 1995-2005. (doi:10.1056/NEJMoa1014618)
-
(2011)
New England Journal of Medicine
, vol.364
, pp. 1995-2005
-
-
De Bono, J.S.1
Logothetis, C.J.2
Molina, A.3
Fizazi, K.4
North, S.5
Chu, L.6
Chi, K.N.7
Jones, R.J.8
Goodman Jr., O.B.9
Saad, F.10
-
7
-
-
0034234580
-
Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer
-
doi:10.1002/1097-0142(20000701)89:1〈123::AID-CNCR17〉3.0.CO;2-9
-
Bostwick DG, Alexander EE, Singh R, Shan A, Qian J, Santella RM, Oberley LW, Yan T, Zhong W, Jiang X et al. 2000 Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer 89 123-134. (doi:10.1002/1097-0142(20000701)89:1〈123::AID- CNCR17〉3.0.CO;2-9)
-
(2000)
Cancer
, vol.89
, pp. 123-134
-
-
Bostwick, D.G.1
Alexander, E.E.2
Singh, R.3
Shan, A.4
Qian, J.5
Santella, R.M.6
Oberley, L.W.7
Yan, T.8
Zhong, W.9
Jiang, X.10
-
8
-
-
65949113815
-
The role of androgen receptor mutations in prostate cancer progression
-
doi:10.2174/138920209787581307
-
Brooke GN & Bevan CL 2009 The role of androgen receptor mutations in prostate cancer progression. Current Genomics 10 18-25. (doi:10.2174/ 138920209787581307)
-
(2009)
Current Genomics
, vol.10
, pp. 18-25
-
-
Brooke, G.N.1
Bevan, C.L.2
-
9
-
-
43449094647
-
Mechanisms of androgen receptor activation in advanced prostate cancer: Differential co-activator recruitment and gene expression
-
doi:10.1038/sj.onc.1210955
-
Brooke GN, Parker MG & Bevan CL 2008 Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression. Oncogene 27 2941-2950. (doi:10.1038/sj.onc.1210955)
-
(2008)
Oncogene
, vol.27
, pp. 2941-2950
-
-
Brooke, G.N.1
Parker, M.G.2
Bevan, C.L.3
-
10
-
-
0034884320
-
Androgen-induced up-regulation of tubulin isoforms in neuroblastoma cells
-
doi:10.1046/j.1471-4159.2001.00475.x
-
Butler R, Leigh PN & Gallo JM 2001 Androgen-induced up-regulation of tubulin isoforms in neuroblastoma cells. Journal of Neurochemistry 78 854-861. (doi:10.1046/j.1471-4159.2001.00475.x)
-
(2001)
Journal of Neurochemistry
, vol.78
, pp. 854-861
-
-
Butler, R.1
Leigh, P.N.2
Gallo, J.M.3
-
11
-
-
1842612441
-
Molecular determinants of resistance to antiandrogen therapy
-
doi:10.1038/nm972
-
Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, Rosenfeld MG & Sawyers CL 2004 Molecular determinants of resistance to antiandrogen therapy. Nature Medicine 10 33-39. (doi:10.1038/nm972)
-
(2004)
Nature Medicine
, vol.10
, pp. 33-39
-
-
Chen, C.D.1
Welsbie, D.S.2
Tran, C.3
Baek, S.H.4
Chen, R.5
Vessella, R.6
Rosenfeld, M.G.7
Sawyers, C.L.8
-
12
-
-
77950878441
-
Pro-survival of estrogen receptor-negative breast cancer cells is regulated by a BLT2-reactive oxygen species-linked signaling pathway
-
doi:10.1093/carcin/bgp203
-
Choi JA, Lee JW, Kim H, Kim EY, Seo JM, Ko J & Kim JH 2010 Pro-survival of estrogen receptor-negative breast cancer cells is regulated by a BLT2-reactive oxygen species-linked signaling pathway. Carcinogenesis 31 543-551. (doi:10.1093/carcin/bgp203)
-
(2010)
Carcinogenesis
, vol.31
, pp. 543-551
-
-
Choi, J.A.1
Lee, J.W.2
Kim, H.3
Kim, E.Y.4
Seo, J.M.5
Ko, J.6
Kim, J.H.7
-
13
-
-
4043153049
-
6-Month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: A randomized controlled trial
-
doi:10.1001/jama.292.7.821
-
D'Amico AV, Manola J, Loffredo M, Renshaw AA, DellaCroce A & Kantoff PW 2004 6-Month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. Journal of the American Medical Association 18 821-827. (doi:10.1001/jama.292.7.821)
-
(2004)
Journal of the American Medical Association
, vol.18
, pp. 821-827
-
-
D'Amico, A.V.1
Manola, J.2
Loffredo, M.3
Renshaw, A.A.4
DellaCroce, A.5
Kantoff, P.W.6
-
14
-
-
38349164176
-
Androgen suppression and radiation vs radiation alone for prostate cancer: A randomized trial
-
doi:10.1001/jama.299.3.289
-
D'Amico AV, Chen MH, Renshaw AA, Loffredo M & Kantoff PW 2008 Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial. Journal of the American Medical Association 23 289-295. (doi:10.1001/jama.299.3.289)
-
(2008)
Journal of the American Medical Association
, vol.23
, pp. 289-295
-
-
D'Amico, A.V.1
Chen, M.H.2
Renshaw, A.A.3
Loffredo, M.4
Kantoff, P.W.5
-
15
-
-
48549089747
-
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
-
doi:10.1158/0008-5472.CAN-08-0594
-
Dehm SM, Schmidt LJ, Heemers HV, Vessella RL & Tindall DJ 2008 Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance. Cancer Research 68 5469-5477. (doi:10.1158/0008-5472.CAN-08-0594)
-
(2008)
Cancer Research
, vol.68
, pp. 5469-5477
-
-
Dehm, S.M.1
Schmidt, L.J.2
Heemers, H.V.3
Vessella, R.L.4
Tindall, D.J.5
-
16
-
-
27744507677
-
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: Results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial
-
doi:10.1016/S1470-2045(05)70348-X
-
Denham JW, Steigler A, Lamb DS, Joseph D, Mameghan H, Turner S, Matthews J, Franklin I, Atkinson C, North J et al. 2005 Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. Lancet Oncology 6 841-850. (doi:10.1016/S1470-2045(05)70348-X)
-
(2005)
Lancet Oncology
, vol.6
, pp. 841-850
-
-
Denham, J.W.1
Steigler, A.2
Lamb, D.S.3
Joseph, D.4
Mameghan, H.5
Turner, S.6
Matthews, J.7
Franklin, I.8
Atkinson, C.9
North, J.10
-
17
-
-
79955470908
-
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial
-
doi:10.1016/S1470-2045(11)70063-8
-
Denham JW, Steigler A, Lamb DS, Joseph D, Mameghan H, Turner S, Matthews J, Atkinson C, North J, Christie D et al. 2011 Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial. Lancet Oncology 12 451-459. (doi:10.1016/S1470- 2045(11)70063-8)
-
(2011)
Lancet Oncology
, vol.12
, pp. 451-459
-
-
Denham, J.W.1
Steigler, A.2
Lamb, D.S.3
Joseph, D.4
Mameghan, H.5
Turner, S.6
Matthews, J.7
Atkinson, C.8
North, J.9
Christie, D.10
-
18
-
-
27644506552
-
Timing is everything: Preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer
-
doi:10.1158/1078-0432.CCR-04-2140
-
Eigl BJ, Eggener SE, Baybik J, Ettinger S, Chi KN, Nelson C, Wang Z & Gleave ME 2005 Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer. Clinical Cancer Research 11 4905-4911. (doi:10.1158/1078-0432.CCR-04-2140)
-
(2005)
Clinical Cancer Research
, vol.11
, pp. 4905-4911
-
-
Eigl, B.J.1
Eggener, S.E.2
Baybik, J.3
Ettinger, S.4
Chi, K.N.5
Nelson, C.6
Wang, Z.7
Gleave, M.E.8
-
19
-
-
1542615071
-
Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence
-
doi:10.1158/0008-5472.CAN-2148-2
-
Ettinger SL, Sobel R, Whitmore TG, Akbari M, Bradley DR, Gleave ME & Nelson CC 2004 Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Research 64 2212-2221. (doi:10.1158/0008-5472.CAN-2148-2)
-
(2004)
Cancer Research
, vol.64
, pp. 2212-2221
-
-
Ettinger, S.L.1
Sobel, R.2
Whitmore, T.G.3
Akbari, M.4
Bradley, D.R.5
Gleave, M.E.6
Nelson, C.C.7
-
20
-
-
65349116534
-
Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition
-
doi:10.1016/j.ccr.2009.03.017
-
Evdokimova V, Tognon C, Ng T, Ruzanov P, Melnyk N, Fink D, Sorokin A, Ovchinnikov LP, Davicioni E, Triche TJ et al. 2009 Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 15 402-415. (doi:10.1016/j.ccr.2009.03.017)
-
(2009)
Cancer Cell
, vol.15
, pp. 402-415
-
-
Evdokimova, V.1
Tognon, C.2
Ng, T.3
Ruzanov, P.4
Melnyk, N.5
Fink, D.6
Sorokin, A.7
Ovchinnikov, L.P.8
Davicioni, E.9
Triche, T.J.10
-
21
-
-
0027238681
-
Two different, overlapping pathways of transcription initiation are active on the TATA-less human androgen receptor promoter. The role of Sp1
-
Faber PW, van Rooij HC, Schipper HJ, Brinkmann AO & Trapman J 1993 Two different, overlapping pathways of transcription initiation are active on the TATA-less human androgen receptor promoter. The role of Sp1. Journal of Biological Chemistry 268 9296-9301. (Pubitemid 23145974)
-
(1993)
Journal of Biological Chemistry
, vol.268
, Issue.13
, pp. 9296-9301
-
-
Faber, P.W.1
Van Rooij, H.C.J.2
Schipper, H.J.3
Brinkmann, A.O.4
Trapman, J.5
-
22
-
-
84858748416
-
The curcumin analog ca27 down-regulates androgen receptor through an oxidative stress mediated mechanism in human prostate cancer cells
-
doi:10.1002/pros.21464
-
Fajardo AM, MacKenzie DA, Ji M, Deck LM, Vander Jagt DL, Thompson TA & Bisoffi M 2012 The curcumin analog ca27 down-regulates androgen receptor through an oxidative stress mediated mechanism in human prostate cancer cells. Prostate 72 612-625. (doi:10.1002/pros.21464)
-
(2012)
Prostate
, vol.72
, pp. 612-625
-
-
Fajardo, A.M.1
MacKenzie, D.A.2
Ji, M.3
Deck, L.M.4
Vander Jagt, D.L.5
Thompson, T.A.6
Bisoffi, M.7
-
23
-
-
84655167067
-
A phase III trial of docetaxel-estramustine in high-risk localised prostate cancer: A planned analysis of response, toxicity and quality of life in the GETUG 12 trial
-
doi:10.1016/j.ejca.2011.10.015
-
Fizazi K, Lesaunier F, Delva R, Gravis G, Rolland F, Priou F, Ferrero JM, Houedé N, Mourey L, Theodore C et al. 2012 A phase III trial of docetaxel-estramustine in high-risk localised prostate cancer: a planned analysis of response, toxicity and quality of life in the GETUG 12 trial. European Journal of Cancer 48 209-217. (doi:10.1016/j.ejca.2011.10.015)
-
(2012)
European Journal of Cancer
, vol.48
, pp. 209-217
-
-
Fizazi, K.1
Lesaunier, F.2
Delva, R.3
Gravis, G.4
Rolland, F.5
Priou, F.6
Ferrero, J.M.7
Houedé, N.8
Mourey, L.9
Theodore, C.10
-
24
-
-
0033304936
-
Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA
-
doi:10.1210/me.13.11.1896
-
Grad JM, Dai JL, Wu S & Burnstein KL 1999 Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA. Molecular Endocrinology 13 1896-1911. (doi:10.1210/me.13.11.1896)
-
(1999)
Molecular Endocrinology
, vol.13
, pp. 1896-1911
-
-
Grad, J.M.1
Dai, J.L.2
Wu, S.3
Burnstein, K.L.4
-
25
-
-
0030707832
-
Combined castration and fractionated radiotherapy in an experimental prostatic adenocarcinoma
-
doi:10.1016/S0360-3016(97)00559-2
-
Granfors T, Damber JE, Bergh A, Landström M, Löfroth PO & Widmark A 1997 Combined castration and fractionated radiotherapy in an experimental prostatic adenocarcinoma. International Journal of Radiation Oncology, Biology, Physics 39 1031-1036. (doi:10.1016/S0360-3016(97)00559-2)
-
(1997)
International Journal of Radiation Oncology, Biology, Physics
, vol.39
, pp. 1031-1036
-
-
Granfors, T.1
Damber, J.E.2
Bergh, A.3
Landström, M.4
Löfroth, P.O.5
Widmark, A.6
-
26
-
-
0032535307
-
Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes
-
Gregory CW, Hamil KG, Kim D, Hall SH, Pretlow TG, Mohler JL & French FS 1998 Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer Research 58 5718-5724. (Pubitemid 29006412)
-
(1998)
Cancer Research
, vol.58
, Issue.24
, pp. 5718-5724
-
-
Gregory, C.W.1
Hamil, K.G.2
Kim, D.3
Hall, S.H.4
Pretlow, T.G.5
Mohler, J.L.6
French, F.S.7
-
27
-
-
65549168746
-
A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth
-
doi:10.1158/0008-5472.CAN-08-3795
-
Guo Z, Yang X, Sun F, Jiang R, Linn DE, Chen H, Chen H, Kong X, Melamed J, Tepper CG et al. 2009 A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth. Cancer Research 69 2305-2313. (doi:10.1158/0008- 5472.CAN-08-3795)
-
(2009)
Cancer Research
, vol.69
, pp. 2305-2313
-
-
Guo, Z.1
Yang, X.2
Sun, F.3
Jiang, R.4
Linn, D.E.5
Chen, H.6
Chen, H.7
Kong, X.8
Melamed, J.9
Tepper, C.G.10
-
29
-
-
78649350746
-
The aging stress response
-
doi:10.1016/j.molcel.2010.10.002
-
Haigis MC & Yankner BA 2010 The aging stress response. Molecular Cell 40 333-344. (doi:10.1016/j.molcel.2010.10.002)
-
(2010)
Molecular Cell
, vol.40
, pp. 333-344
-
-
Haigis, M.C.1
Yankner, B.A.2
-
30
-
-
37349118115
-
Androgen receptor (AR) coregulators: A diversity of functions converging on and regulating the AR transcriptional complex
-
doi:10.1210/er.2007-0019
-
Heemers HV & Tindall DJ 2007 Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocrine Reviews 28 778-808. (doi:10.1210/er.2007-0019)
-
(2007)
Endocrine Reviews
, vol.28
, pp. 778-808
-
-
Heemers, H.V.1
Tindall, D.J.2
-
31
-
-
53049109168
-
BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation
-
doi:10.1038/sj.bjc.6604655
-
Hennig R, Osman T, Esposito I, Giese N, Rao SM, Ding XZ, Tong WG, Büchler MW, Yokomizo T, Friess H et al. 2008 BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation. British Journal of Cancer 99 1064-1073. (doi:10.1038/sj.bjc.6604655)
-
(2008)
British Journal of Cancer
, vol.99
, pp. 1064-1073
-
-
Hennig, R.1
Osman, T.2
Esposito, I.3
Giese, N.4
Rao, S.M.5
Ding, X.Z.6
Tong, W.G.7
Büchler, M.W.8
Yokomizo, T.9
Friess, H.10
-
32
-
-
58249110391
-
Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer
-
doi:10.1158/0008-5472.CAN-08-2764
-
Hu R, Dunn TA, Wei S, Isharwal S, Veltri RW, Humphreys E, Han M, Partin AW, Vessella RL, Isaacs WB et al. 2009 Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer. Cancer Research 69 16-22. (doi:10.1158/0008-5472.CAN-08-2764)
-
(2009)
Cancer Research
, vol.69
, pp. 16-22
-
-
Hu, R.1
Dunn, T.A.2
Wei, S.3
Isharwal, S.4
Veltri, R.W.5
Humphreys, E.6
Han, M.7
Partin, A.W.8
Vessella, R.L.9
Isaacs, W.B.10
-
33
-
-
77950879014
-
Androgen receptor survival signaling is blocked by anti-β2- microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells
-
doi:10.1074/jbc.M109.092759
-
Huang WC, Zhau HE & Chung LW 2010 Androgen receptor survival signaling is blocked by anti-β2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells. Journal of Biological Chemistry 285 7947-7956. (doi:10.1074/jbc.M109.092759)
-
(2010)
Journal of Biological Chemistry
, vol.285
, pp. 7947-7956
-
-
Huang, W.C.1
Zhau, H.E.2
Chung, L.W.3
-
34
-
-
84862908756
-
Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells
-
doi:10.1158/1541-7786.MCR-11-0206
-
Huang WC, Li X, Liu J, Lin J & Chung LW 2012 Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells. Molecular Cancer Research 10 133-142. (doi:10.1158/1541-7786.MCR-11-0206)
-
(2012)
Molecular Cancer Research
, vol.10
, pp. 133-142
-
-
Huang, W.C.1
Li, X.2
Liu, J.3
Lin, J.4
Chung, L.W.5
-
35
-
-
79954629408
-
Long-term mequindox treatment induced endocrine and reproductive toxicity via oxidative stress in male Wistar rats
-
doi:10.1016/j.taap.2011.02.020
-
Ihsan A, Wang X, Liu Z, Wang Y, Huang X, Liu Y, Yu H, Zhang H, Li T, Yang C et al. 2011 Long-term mequindox treatment induced endocrine and reproductive toxicity via oxidative stress in male Wistar rats. Toxicology and Applied Pharmacology 252 281-288. (doi:10.1016/j.taap.2011.02.020)
-
(2011)
Toxicology and Applied Pharmacology
, vol.252
, pp. 281-288
-
-
Ihsan, A.1
Wang, X.2
Liu, Z.3
Wang, Y.4
Huang, X.5
Liu, Y.6
Yu, H.7
Zhang, H.8
Li, T.9
Yang, C.10
-
36
-
-
77954823967
-
Androgen receptor counteracts doxorubicin-induced cardiotoxicity in male mice
-
doi:10.1210/me.2009-0402
-
Ikeda Y, Aihara K, Akaike M, Sato T, Ishikawa K, Ise T, Yagi S, Iwase T, Ueda Y, Yoshida S et al. 2010 Androgen receptor counteracts doxorubicin-induced cardiotoxicity in male mice. Molecular Endocrinology 24 1338-1348. (doi:10.1210/me.2009-0402)
-
(2010)
Molecular Endocrinology
, vol.24
, pp. 1338-1348
-
-
Ikeda, Y.1
Aihara, K.2
Akaike, M.3
Sato, T.4
Ishikawa, K.5
Ise, T.6
Yagi, S.7
Iwase, T.8
Ueda, Y.9
Yoshida, S.10
-
37
-
-
79960227242
-
Radiotherapy and short-term androgen deprivation for localized prostate cancer
-
doi:10.1056/NEJMoa1012348
-
Jones CU, Hunt D, McGowan DG, Amin MB, Chetner MP, Bruner DW, Leibenhaut MH, Husain SM, Rotman M, Souhami L et al. 2011 Radiotherapy and short-term androgen deprivation for localized prostate cancer. New England Journal of Medicine 365 107-118. (doi:10.1056/NEJMoa1012348)
-
(2011)
New England Journal of Medicine
, vol.365
, pp. 107-118
-
-
Jones, C.U.1
Hunt, D.2
McGowan, D.G.3
Amin, M.B.4
Chetner, M.P.5
Bruner, D.W.6
Leibenhaut, M.H.7
Husain, S.M.8
Rotman, M.9
Souhami, L.10
-
38
-
-
0042566204
-
Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growth
-
doi:10.1016/S0360-3016(03)00539-X
-
Kaminski JM, Hanlon AL, Joon DL, Meistrich M, Hachem P & Pollack A 2003 Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growth. International Journal of Radiation Oncology, Biology, Physics 57 24-28. (doi:10.1016/S0360-3016(03)00539-X)
-
(2003)
International Journal of Radiation Oncology, Biology, Physics
, vol.57
, pp. 24-28
-
-
Kaminski, J.M.1
Hanlon, A.L.2
Joon, D.L.3
Meistrich, M.4
Hachem, P.5
Pollack, A.6
-
39
-
-
1542438630
-
Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer
-
doi:10.1200/JCO.2003.05.046
-
Kattan MW, Zelefsky MJ, Kupelian PA, Cho D, Scardino PT, Fuks Z & Leibel SA 2003 Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. Journal of Clinical Oncology 21 4568-4571. (doi:10.1200/JCO.2003.05.046)
-
(2003)
Journal of Clinical Oncology
, vol.21
, pp. 4568-4571
-
-
Kattan, M.W.1
Zelefsky, M.J.2
Kupelian, P.A.3
Cho, D.4
Scardino, P.T.5
Fuks, Z.6
Leibel, S.A.7
-
40
-
-
67650173313
-
Oxidative stress in prostate cancer
-
doi:10.1016/j.canlet.2008.12.011
-
Khandrika L, Kumar B, Koul S, Maroni P & Koul HK 2009 Oxidative stress in prostate cancer. Cancer Letters 282 125-136. (doi:10.1016/j.canlet. 2008.12.011)
-
(2009)
Cancer Letters
, vol.282
, pp. 125-136
-
-
Khandrika, L.1
Kumar, B.2
Koul, S.3
Maroni, P.4
Koul, H.K.5
-
41
-
-
77953178795
-
Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: Role of reactive oxygen species
-
doi:10.1258/ebm.2010.009369
-
Koka PS, Mondal D, Schultz M, Abdel-Mageed AB & Agrawal KC 2010 Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species. Experimental Biology and Medicine 235 751-760. (doi:10.1258/ebm.2010.009369)
-
(2010)
Experimental Biology and Medicine
, vol.235
, pp. 751-760
-
-
Koka, P.S.1
Mondal, D.2
Schultz, M.3
Abdel-Mageed, A.B.4
Agrawal, K.C.5
-
42
-
-
79955847465
-
Long-term androgen ablation and docetaxel up-regulate phosphorylated Akt in castration resistant prostate cancer
-
doi:10.1016/j.juro.2011.02.016
-
Kosaka T, Miyajima A, Shirotake S, Suzuki E, Kikuchi E & Oya M 2011 Long-term androgen ablation and docetaxel up-regulate phosphorylated Akt in castration resistant prostate cancer. Journal of Urology 85 2376-2381. (doi:10.1016/j.juro.2011.02.016)
-
(2011)
Journal of Urology
, vol.85
, pp. 2376-2381
-
-
Kosaka, T.1
Miyajima, A.2
Shirotake, S.3
Suzuki, E.4
Kikuchi, E.5
Oya, M.6
-
43
-
-
79952104214
-
Activation of a non-genomic Pim-1/Bad-Pser75 module is required for an efficient pro-survival effect of Bcl-xL induced by androgen in LNCaP cells
-
doi:10.1016/j.biocel.2010.12.017
-
Kumar JK, Ping RY, Teong HF, Goh S & Clément MV 2011 Activation of a non-genomic Pim-1/Bad-Pser75 module is required for an efficient pro-survival effect of Bcl-xL induced by androgen in LNCaP cells. International Journal of Biochemistry & Cell Biology 43 594-603. (doi:10.1016/j.biocel. 2010.12.017)
-
(2011)
International Journal of Biochemistry & Cell Biology
, vol.43
, pp. 594-603
-
-
Kumar, J.K.1
Ping, R.Y.2
Teong, H.F.3
Goh, S.4
Clément, M.V.5
-
44
-
-
20144387062
-
High molecularmass proteome of androgen-independent prostate cancer
-
doi:10.1002/pmic.200401115
-
Kuruma H, Egawa S, Oh-Ishi M, Kodera Y, Satoh M, Chen W, Okusa H, Matsumoto K, Maeda T & Baba S 2005 High molecularmass proteome of androgen-independent prostate cancer. Proteomics 5 1097-1112. (doi:10.1002/pmic.200401115)
-
(2005)
Proteomics
, vol.5
, pp. 1097-1112
-
-
Kuruma, H.1
Egawa, S.2
Oh-Ishi, M.3
Kodera, Y.4
Satoh, M.5
Chen, W.6
Okusa, H.7
Matsumoto, K.8
Maeda, T.9
Baba, S.10
-
45
-
-
1842668004
-
Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells
-
Lee SO, Lou W, Hou M, de Miguel F, Gerber L & Gao AC 2003 Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells. Clinical Cancer Research 9 370-376. (Pubitemid 36109754)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.1 I
, pp. 370-376
-
-
Lee, S.O.1
Lou, W.2
Hou, M.3
De Miguel, F.4
Gerber, L.5
Gao, A.C.6
-
46
-
-
59849107713
-
Endothelin-1 enhances the expression of the androgen receptor via activation of the c-myc pathway in prostate cancer cells
-
doi:10.1002/mc.20462
-
Lee JG, Zheng R, McCafferty-Cepero JM, Burnstein KL, Nanus DM & Shen R 2009 Endothelin-1 enhances the expression of the androgen receptor via activation of the c-myc pathway in prostate cancer cells. Molecular Carcinogenesis 48 141-149. (doi:10.1002/mc.20462)
-
(2009)
Molecular Carcinogenesis
, vol.48
, pp. 141-149
-
-
Lee, J.G.1
Zheng, R.2
McCafferty-Cepero, J.M.3
Burnstein, K.L.4
Nanus, D.M.5
Shen, R.6
-
47
-
-
84862793197
-
Androgen receptor is up-regulated by a BLT2-linked pathway to contribute to prostate cancer progression
-
doi:10.1016/j.bbrc.2012.03.012
-
Lee JW, Kim GY & Kim JH 2012 Androgen receptor is up-regulated by a BLT2-linked pathway to contribute to prostate cancer progression. Biochemical and Biophysical Research Communications 420 428-433. (doi:10.1016/j.bbrc.2012. 03.012)
-
(2012)
Biochemical and Biophysical Research Communications
, vol.420
, pp. 428-433
-
-
Lee, J.W.1
Kim, G.Y.2
Kim, J.H.3
-
48
-
-
51049098138
-
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
-
doi:10.1158/0008-5472.CAN-07-5997
-
Locke JA, Guns ES, Lubik AA, Adomat HH, Hendy SC, Wood CA, Ettinger SL, Gleave ME & Nelson CC 2008 Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer. Cancer Research 68 6407-6415. (doi:10.1158/0008-5472.CAN-07-5997)
-
(2008)
Cancer Research
, vol.68
, pp. 6407-6415
-
-
Locke, J.A.1
Guns, E.S.2
Lubik, A.A.3
Adomat, H.H.4
Hendy, S.C.5
Wood, C.A.6
Ettinger, S.L.7
Gleave, M.E.8
Nelson, C.C.9
-
49
-
-
84862693127
-
Ack1-mediated androgen receptor phosphorylation modulates radiation resistance in castration-resistant prostate cancer
-
doi:10.1074/jbc.M112.357384
-
Mahajan K, Coppola D, Rawal B, Chen YA, Lawrence HR, Engelman RW, Lawrence NJ & Mahajan NP 2012 Ack1-mediated androgen receptor phosphorylation modulates radiation resistance in castration-resistant prostate cancer. Journal of Biological Chemistry 287 22112-22122. (doi:10.1074/jbc.M112. 357384)
-
(2012)
Journal of Biological Chemistry
, vol.287
, pp. 22112-22122
-
-
Mahajan, K.1
Coppola, D.2
Rawal, B.3
Chen, Y.A.4
Lawrence, H.R.5
Engelman, R.W.6
Lawrence, N.J.7
Mahajan, N.P.8
-
50
-
-
84861168754
-
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer
-
doi:10.1158/1078-0432.CCR-11-2318
-
Mariani M, Zannoni GF, Sioletic S, Sieber S, Martino C, Martinelli E, Coco C, Scambia G, Shahabi S & Ferlini C 2012 Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer. Clinical Cancer Research 18 2964-2975. (doi:10.1158/1078-0432.CCR-11-2318)
-
(2012)
Clinical Cancer Research
, vol.18
, pp. 2964-2975
-
-
Mariani, M.1
Zannoni, G.F.2
Sioletic, S.3
Sieber, S.4
Martino, C.5
Martinelli, E.6
Coco, C.7
Scambia, G.8
Shahabi, S.9
Ferlini, C.10
-
51
-
-
9644279380
-
Androgen deprivation therapy for prostate cancer: Current status and future prospects
-
doi:10.1002/pros.20115
-
Miyamoto H, Messing EM & Chang C 2004 Androgen deprivation therapy for prostate cancer: current status and future prospects. Prostate 61 332-353. (doi:10.1002/pros.20115)
-
(2004)
Prostate
, vol.61
, pp. 332-353
-
-
Miyamoto, H.1
Messing, E.M.2
Chang, C.3
-
52
-
-
0028107468
-
Identification of 3′,5′-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter
-
doi:10.1210/me.8.1.77
-
Mizokami A, Yeh SY & Chang C 1994 Identification of 3′,5′-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter. Molecular Endocrinology 8 77-88. (doi:10.1210/me.8.1.77)
-
(1994)
Molecular Endocrinology
, vol.8
, pp. 77-88
-
-
Mizokami, A.1
Yeh, S.Y.2
Chang, C.3
-
53
-
-
49249119358
-
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
-
doi:10.1158/0008-5472.CAN-08-0249
-
Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, True LD & Nelson PS 2008 Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth. Cancer Research 68 4447-4454. (doi:10.1158/0008-5472.CAN-08-0249)
-
(2008)
Cancer Research
, vol.68
, pp. 4447-4454
-
-
Montgomery, R.B.1
Mostaghel, E.A.2
Vessella, R.3
Hess, D.L.4
Kalhorn, T.F.5
Higano, C.S.6
True, L.D.7
Nelson, P.S.8
-
54
-
-
84856652439
-
Beyond castration-defining future directions in the hormonal treatment of prostate cancer
-
doi:10.1007/s12672-011-0096-0
-
Niraula S, Chi K & Joshua AM 2012 Beyond castration-defining future directions in the hormonal treatment of prostate cancer. Hormones & Cancer 3 3-13. (doi:10.1007/s12672-011-0096-0)
-
(2012)
Hormones & Cancer
, vol.3
, pp. 3-13
-
-
Niraula, S.1
Chi, K.2
Joshua, A.M.3
-
55
-
-
84858292115
-
Androgen deprivation therapy in combination with radiotherapy for high-risk clinically localized prostate cancer
-
doi:10.1016/j.jsbmb.2011.12.019
-
Nishiyama T 2012 Androgen deprivation therapy in combination with radiotherapy for high-risk clinically localized prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 129 179-190. (doi:10.1016/j.jsbmb. 2011.12.019)
-
(2012)
Journal of Steroid Biochemistry and Molecular Biology
, vol.129
, pp. 179-190
-
-
Nishiyama, T.1
-
56
-
-
33845384384
-
Unique CCT repeats mediate transcription of the TWIST1 gene in mesenchymal cell lines
-
doi:10.1016/j.bbrc.2006.11.114
-
Ohkuma M, Funato N, Higashihori N, Murakami M, Ohyama K & Nakamura M 2007 Unique CCT repeats mediate transcription of the TWIST1 gene in mesenchymal cell lines. Biochemical and Biophysical Research Communications 352 925-931. (doi:10.1016/j.bbrc.2006.11.114)
-
(2007)
Biochemical and Biophysical Research Communications
, vol.352
, pp. 925-931
-
-
Ohkuma, M.1
Funato, N.2
Higashihori, N.3
Murakami, M.4
Ohyama, K.5
Nakamura, M.6
-
57
-
-
0036892849
-
Gene expression profiling of androgen deficiency predicts a pathway of prostate apoptosis that involves genes related to oxidative stress
-
doi:10.1210/en.2002-220327
-
Pang ST, Dillner K, Wu X, Pousette A, Norstedt G & Flores-Morales A 2002 Gene expression profiling of androgen deficiency predicts a pathway of prostate apoptosis that involves genes related to oxidative stress. Endocrinology 143 4897-4906. (doi:10.1210/en.2002-220327)
-
(2002)
Endocrinology
, vol.143
, pp. 4897-4906
-
-
Pang, S.T.1
Dillner, K.2
Wu, X.3
Pousette, A.4
Norstedt, G.5
Flores-Morales, A.6
-
58
-
-
33745193908
-
Redox signaling in hypertension
-
doi:10.1016/j.cardiores.2006.05.001
-
Paravicini TM & Touyz RM 2006 Redox signaling in hypertension. Cardiovascular Research 71 247-258. (doi:10.1016/j.cardiores.2006.05.001)
-
(2006)
Cardiovascular Research
, vol.71
, pp. 247-258
-
-
Paravicini, T.M.1
Touyz, R.M.2
-
59
-
-
38949156821
-
Androgen manipulation alters oxidative DNA adduct levels in androgen-sensitive prostate cancer cells grown in vitro and in vivo
-
doi:10.1016/j.canlet.2007.11.015
-
Pathak S, Singh R, Verschoyle RD, Greaves P, Farmer PB, Steward WP, Mellon JK, Gescher AJ & Sharma RA 2008 Androgen manipulation alters oxidative DNA adduct levels in androgen-sensitive prostate cancer cells grown in vitro and in vivo. Cancer Letters 261 74-83. (doi:10.1016/j.canlet.2007.11.015)
-
(2008)
Cancer Letters
, vol.261
, pp. 74-83
-
-
Pathak, S.1
Singh, R.2
Verschoyle, R.D.3
Greaves, P.4
Farmer, P.B.5
Steward, W.P.6
Mellon, J.K.7
Gescher, A.J.8
Sharma, R.A.9
-
60
-
-
34347358621
-
Upregulation of Twist-1 by NF-κB blocks cytotoxicity induced by chemotherapeutic drugs
-
doi:10.1128/MCB.01219-06
-
Pham CG, Bubici C, Zazzeroni F, Knabb JR, Papa S, Kuntzen C & Franzoso G 2007 Upregulation of Twist-1 by NF-κB blocks cytotoxicity induced by chemotherapeutic drugs. Molecular and Cellular Biology 27 3920-3935. (doi:10.1128/MCB.01219-06)
-
(2007)
Molecular and Cellular Biology
, vol.27
, pp. 3920-3935
-
-
Pham, C.G.1
Bubici, C.2
Zazzeroni, F.3
Knabb, J.R.4
Papa, S.5
Kuntzen, C.6
Franzoso, G.7
-
61
-
-
33846844835
-
Androgen induces adaptation to oxidative stress in prostate cancer: Implications for treatment with radiation therapy
-
doi:10.1593/neo.06739
-
Pinthus JH, Bryskin I, Trachtenberg J, Lu JP, Singh G, Fridman E & Wilson BC 2007 Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy. Neoplasia 9 68-80. (doi:10.1593/neo.06739)
-
(2007)
Neoplasia
, vol.9
, pp. 68-80
-
-
Pinthus, J.H.1
Bryskin, I.2
Trachtenberg, J.3
Lu, J.P.4
Singh, G.5
Fridman, E.6
Wilson, B.C.7
-
62
-
-
68549107700
-
Upregulation of manganese superoxide dismutase (SOD2) is a common pathway for neuroendocrine differentiation in prostate cancer cells
-
doi:10.1002/ijc.24501
-
Quirós I, Sáinz RM, Hevia D, García-Suárez O, Astudillo A, Rivas M & Mayo JC 2009 Upregulation of manganese superoxide dismutase (SOD2) is a common pathway for neuroendocrine differentiation in prostate cancer cells. International Journal of Cancer 125 1497-1504. (doi:10.1002/ijc.24501)
-
(2009)
International Journal of Cancer
, vol.125
, pp. 1497-1504
-
-
Quirós, I.1
Sáinz, R.M.2
Hevia, D.3
García-Suárez, O.4
Astudillo, A.5
Rivas, M.6
Mayo, J.C.7
-
63
-
-
84857116578
-
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
-
doi:10.1016/j.cellsig.2012.01.008
-
Ray PD, Huang BW & Tsuji Y 2012 Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cellular Signaling 24 981-990. (doi:10.1016/j.cellsig.2012.01.008)
-
(2012)
Cellular Signaling
, vol.24
, pp. 981-990
-
-
Ray, P.D.1
Huang, B.W.2
Tsuji, Y.3
-
64
-
-
0031020769
-
Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells
-
doi:10.1093/jnci/89.1.40
-
Ripple MO, Henry WF, Rago RP & Wilding G 1997 Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. Journal of the National Cancer Institute 89 40-48. (doi:10.1093/jnci/89.1.40)
-
(1997)
Journal of the National Cancer Institute
, vol.89
, pp. 40-48
-
-
Ripple, M.O.1
Henry, W.F.2
Rago, R.P.3
Wilding, G.4
-
65
-
-
79959340042
-
Protein sulfenic acid formation: From cellular damage to redox regulation
-
doi:10.1016/j.freeradbiomed.2011.04.031
-
Roos G & Messens J 2011 Protein sulfenic acid formation: from cellular damage to redox regulation. Free Radical Biology & Medicine 51 314-326. (doi:10.1016/j.freeradbiomed.2011.04.031)
-
(2011)
Free Radical Biology & Medicine
, vol.51
, pp. 314-326
-
-
Roos, G.1
Messens, J.2
-
66
-
-
33644675811
-
Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
-
doi:10.1200/JCO.2005.03.4777
-
Scher HI & Sawyers CL 2005 Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. Journal of Clinical Oncology 23 8253-8261. (doi:10.1200/JCO.2005.03.4777)
-
(2005)
Journal of Clinical Oncology
, vol.23
, pp. 8253-8261
-
-
Scher, H.I.1
Sawyers, C.L.2
-
67
-
-
84866770294
-
Increased survival with enzalutamide in prostate cancer after chemotherapy
-
doi:10.1056/NEJMoa1207506
-
Scher HI, Fizazi K, Saad F, Taplin ME, Sternberg CN, Miller MD, de Wit R, Mulders P, Chi KN, Shore ND et al. 2012 Increased survival with enzalutamide in prostate cancer after chemotherapy. New England Journal of Medicine 367 1187-1197. (doi:10.1056/NEJMoa1207506)
-
(2012)
New England Journal of Medicine
, vol.367
, pp. 1187-1197
-
-
Scher, H.I.1
Fizazi, K.2
Saad, F.3
Taplin, M.E.4
Sternberg, C.N.5
Miller, M.D.6
De Wit, R.7
Mulders, P.8
Chi, K.N.9
Shore, N.D.10
-
68
-
-
78650171625
-
Thioredoxin 1 as a subcellular biomarker of redox imbalance in human prostate cancer progression
-
doi:10.1016/j.freeradbiomed.2010.10.691
-
Shan W, Zhong W, Zhao R & Oberley TD 2010 Thioredoxin 1 as a subcellular biomarker of redox imbalance in human prostate cancer progression. Free Radical Biology & Medicine 49 2078-2087. (doi:10.1016/j.freeradbiomed. 2010.10.691)
-
(2010)
Free Radical Biology & Medicine
, vol.49
, pp. 2078-2087
-
-
Shan, W.1
Zhong, W.2
Zhao, R.3
Oberley, T.D.4
-
69
-
-
0035667565
-
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis
-
doi:10.1016/S0090-4295(01)01405-4
-
Shariat SF, Andrews B, Kattan MW, Kim J, Wheeler TM & Slawin KM 2001 Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology 58 1008-1015. (doi:10.1016/S0090-4295(01)01405-4)
-
(2001)
Urology
, vol.58
, pp. 1008-1015
-
-
Shariat, S.F.1
Andrews, B.2
Kattan, M.W.3
Kim, J.4
Wheeler, T.M.5
Slawin, K.M.6
-
70
-
-
58149165089
-
Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: Implications for castration-resistant prostate cancer
-
doi:10.1158/1078-0432.CCR-08-0591
-
Sharifi N, Hurt EM, Thomas SB & Farrar WL 2008 Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer. Clinical Cancer Research 14 6073-6080. (doi:10.1158/1078-0432.CCR-08-0591)
-
(2008)
Clinical Cancer Research
, vol.14
, pp. 6073-6080
-
-
Sharifi, N.1
Hurt, E.M.2
Thomas, S.B.3
Farrar, W.L.4
-
71
-
-
34248207325
-
Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells
-
doi:10.1002/pros.20565
-
Shigemura K, Sung SY, Kubo H, Arnold RS, Fujisawa M, Gotoh A, Zhau HE & Chung LW 2007 Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells. Prostate 67 722-731. (doi:10.1002/pros.20565)
-
(2007)
Prostate
, vol.67
, pp. 722-731
-
-
Shigemura, K.1
Sung, S.Y.2
Kubo, H.3
Arnold, R.S.4
Fujisawa, M.5
Gotoh, A.6
Zhau, H.E.7
Chung, L.W.8
-
72
-
-
39149103407
-
Twist promotes tumor cell growth through YB-1 expression
-
doi:10.1158/0008-5472.CAN-07-2981
-
Shiota M, Izumi H, Onitsuka T, Miyamoto N, Kashiwagi E, Kidani A, Yokomizo A, Naito S & Kohno K 2008a Twist promotes tumor cell growth through YB-1 expression. Cancer Research 68 98-105. (doi:10.1158/0008-5472.CAN-07-2981)
-
(2008)
Cancer Research
, vol.68
, pp. 98-105
-
-
Shiota, M.1
Izumi, H.2
Onitsuka, T.3
Miyamoto, N.4
Kashiwagi, E.5
Kidani, A.6
Yokomizo, A.7
Naito, S.8
Kohno, K.9
-
73
-
-
52149111636
-
Twist and p53 reciprocally regulate target genes via direct interaction
-
doi:10.1038/onc.2008.176
-
Shiota M, Izumi H, Onitsuka T, Miyamoto N, Kashiwagi E, Kidani A, Hirano G, Takahashi M, Naito S & Kohno K 2008b Twist and p53 reciprocally regulate target genes via direct interaction. Oncogene 27 5543-5553. (doi:10.1038/onc. 2008.176)
-
(2008)
Oncogene
, vol.27
, pp. 5543-5553
-
-
Shiota, M.1
Izumi, H.2
Onitsuka, T.3
Miyamoto, N.4
Kashiwagi, E.5
Kidani, A.6
Hirano, G.7
Takahashi, M.8
Naito, S.9
Kohno, K.10
-
74
-
-
66149147100
-
Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth
-
doi:10.1158/0008-5472.CAN-08-2334
-
Shiota M, Izumi H, Tanimoto A, Takahashi M, Miyamoto N, Kashiwagi E, Kidani A, Hirano G, Masubuchi D, Fukunaka Y et al. 2009 Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth. Cancer Research 69 3148-3156. (doi:10.1158/0008-5472.CAN-08-2334)
-
(2009)
Cancer Research
, vol.69
, pp. 3148-3156
-
-
Shiota, M.1
Izumi, H.2
Tanimoto, A.3
Takahashi, M.4
Miyamoto, N.5
Kashiwagi, E.6
Kidani, A.7
Hirano, G.8
Masubuchi, D.9
Fukunaka, Y.10
-
75
-
-
74449089780
-
Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression
-
doi:10.1038/onc.2009.322
-
Shiota M, Yokomizo A, Tada Y, Inokuchi J, Kashiwagi E, Masubuchi D, Eto M, Uchiumi T & Naito S 2010 Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression. Oncogene 29 237-250. (doi:10.1038/onc.2009.322)
-
(2010)
Oncogene
, vol.29
, pp. 237-250
-
-
Shiota, M.1
Yokomizo, A.2
Tada, Y.3
Inokuchi, J.4
Kashiwagi, E.5
Masubuchi, D.6
Eto, M.7
Uchiumi, T.8
Naito, S.9
-
76
-
-
80052270884
-
Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer
-
doi:10.1016/j.freeradbiomed.2011.07.011
-
Shiota M, Yokomizo A & Naito S 2011a Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer. Free Radical Biology & Medicine 51 1320-1328. (doi:10.1016/j.freeradbiomed.2011.07.011)
-
(2011)
Free Radical Biology & Medicine
, vol.51
, pp. 1320-1328
-
-
Shiota, M.1
Yokomizo, A.2
Naito, S.3
-
77
-
-
79960979238
-
Increased androgen receptor transcription: A cause of castration-resistant prostate cancer and a possible therapeutic target
-
doi:10.1530/JME-11-0018
-
Shiota M, Yokomizo A & Naito S 2011b Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target. Journal of Molecular Endocrinology 47 R25-R41. (doi:10.1530/JME-11-0018)
-
(2011)
Journal of Molecular Endocrinology
, vol.47
-
-
Shiota, M.1
Yokomizo, A.2
Naito, S.3
-
78
-
-
80052161751
-
Y-box binding protein-1 promotes androgen-independent prostate cancer cell growth through androgen receptor expression
-
doi:10.1530/ERC-11-0017
-
Shiota M, Takeuchi A, Song Y, Yokomizo A, Kashiwagi E, Uchiumi T, Kuroiwa K, Tatsugami K, Fujimoto N, Oda Y et al. 2011c Y-box binding protein-1 promotes androgen-independent prostate cancer cell growth through androgen receptor expression. Endocrine-Related Cancer 18 505-517. (doi:10.1530/ERC-11-0017)
-
(2011)
Endocrine-Related Cancer
, vol.18
, pp. 505-517
-
-
Shiota, M.1
Takeuchi, A.2
Song, Y.3
Yokomizo, A.4
Kashiwagi, E.5
Uchiumi, T.6
Kuroiwa, K.7
Tatsugami, K.8
Fujimoto, N.9
Oda, Y.10
-
79
-
-
80051692745
-
Androgen receptor cofactors in prostate cancer: Potential therapeutic targets of castration-resistant prostate cancer
-
doi:10.2174/156800911796798904
-
Shiota M, Yokomizo A & Naito S 2011d Androgen receptor cofactors in prostate cancer: potential therapeutic targets of castration-resistant prostate cancer. Current Cancer Drug Targets 11 870-881. (doi:10.2174/156800911796798904)
-
(2011)
Current Cancer Drug Targets
, vol.11
, pp. 870-881
-
-
Shiota, M.1
Yokomizo, A.2
Naito, S.3
-
80
-
-
79957938567
-
Peroxiredoxin 2 in nucleus and cytoplasm distinctly regulates androgen receptor signaling in prostate cancer cells
-
doi:10.1016/j.freeradbiomed.2011.04.001
-
Shiota M, Yokomizo A, Kashiwagi E, Takeuchi A, Fujimoto N, Uchiumi T & Naito S 2011e Peroxiredoxin 2 in nucleus and cytoplasm distinctly regulates androgen receptor signaling in prostate cancer cells. Free Radical Biology & Medicine 51 78-87. (doi:10.1016/j.freeradbiomed.2011.04.001)
-
(2011)
Free Radical Biology & Medicine
, vol.51
, pp. 78-87
-
-
Shiota, M.1
Yokomizo, A.2
Kashiwagi, E.3
Takeuchi, A.4
Fujimoto, N.5
Uchiumi, T.6
Naito, S.7
-
81
-
-
84862146158
-
Androgen receptor signaling regulates cell growth and vulnerability to doxorubicin in bladder cancer
-
doi:10.1016/j.juro.2012.02.2554
-
Shiota M, Takeuchi A, Yokomizo A, Kashiwagi E, Tatsugami K, Kuroiwa K & Naito S 2012 Androgen receptor signaling regulates cell growth and vulnerability to doxorubicin in bladder cancer. Journal of Urology 188 276-286. (doi:10.1016/j.juro.2012.02.2554)
-
(2012)
Journal of Urology
, vol.188
, pp. 276-286
-
-
Shiota, M.1
Takeuchi, A.2
Yokomizo, A.3
Kashiwagi, E.4
Tatsugami, K.5
Kuroiwa, K.6
Naito, S.7
-
82
-
-
70349740916
-
Reactive oxygen species directly modify sodium-calcium exchanger activity in a splice variant-dependent manner
-
doi:10.1016/j.yjmcc.2009.05.011
-
Soliman D, Hamming KS, Matemisz LC & Light PE 2009 Reactive oxygen species directly modify sodium-calcium exchanger activity in a splice variant-dependent manner. Journal of Molecular & Cellular Cardiology 47 595-602. (doi:10.1016/j.yjmcc.2009.05.011)
-
(2009)
Journal of Molecular & Cellular Cardiology
, vol.47
, pp. 595-602
-
-
Soliman, D.1
Hamming, K.S.2
Matemisz, L.C.3
Light, P.E.4
-
83
-
-
33645056171
-
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer
-
doi:10.1158/0008-5472.CAN-05-4000
-
Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM, Febbo PG & Balk SP 2006 Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Research 66 2815-2825. (doi:10.1158/0008-5472.CAN-05-4000)
-
(2006)
Cancer Research
, vol.66
, pp. 2815-2825
-
-
Stanbrough, M.1
Bubley, G.J.2
Ross, K.3
Golub, T.R.4
Rubin, M.A.5
Penning, T.M.6
Febbo, P.G.7
Balk, S.P.8
-
84
-
-
77955296562
-
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
-
doi:10.1172/JCI41824
-
Sun S, Sprenger CC, Vessella RL, Haugk K, Soriano K, Mostaghel EA, Page ST, Coleman IM, Nguyen HM, Sun H et al. 2010 Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant. Journal of Clinical Investigation 120 2715-2730. (doi:10.1172/JCI41824)
-
(2010)
Journal of Clinical Investigation
, vol.120
, pp. 2715-2730
-
-
Sun, S.1
Sprenger, C.C.2
Vessella, R.L.3
Haugk, K.4
Soriano, K.5
Mostaghel, E.A.6
Page, S.T.7
Coleman, I.M.8
Nguyen, H.M.9
Sun, H.10
-
85
-
-
68849110620
-
Oxidative stress-induced alternative splicing of transformer 2b (SFRS10) and CD44 pre-mRNAs in gastric epithelial cells
-
doi:10.1152/ajpcell.00009.2009
-
Takeo K, Kawai T, Nishida K, Masuda K, Teshima-Kondo S, Tanahashi T & Rokutan K 2009 Oxidative stress-induced alternative splicing of transformer 2b (SFRS10) and CD44 pre-mRNAs in gastric epithelial cells. American Journal of Physiology. Cell Physiology 297 C330-C338. (doi:10.1152/ajpcell.00009.2009)
-
(2009)
American Journal of Physiology. Cell Physiology
, vol.297
-
-
Takeo, K.1
Kawai, T.2
Nishida, K.3
Masuda, K.4
Teshima-Kondo, S.5
Tanahashi, T.6
Rokutan, K.7
-
86
-
-
0344844531
-
Androgenic regulation of oxidative stress in the rat prostate: Involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth
-
doi:10.1016/S0002-9440(10)63606-1
-
Tam NN, Gao Y, Leung YK & Ho SM 2003 Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth. American Journal of Pathology 163 2513-2522. (doi:10.1016/S0002-9440(10)63606-1)
-
(2003)
American Journal of Pathology
, vol.163
, pp. 2513-2522
-
-
Tam, N.N.1
Gao, Y.2
Leung, Y.K.3
Ho, S.M.4
-
87
-
-
84855709289
-
SOD mimetics: A novel class of androgen receptor inhibitors that suppresses castration-resistant growth of prostate cancer
-
doi:10.1158/1535-7163.MCT-11-0540
-
Thomas R & Sharifi N 2012 SOD mimetics: a novel class of androgen receptor inhibitors that suppresses castration-resistant growth of prostate cancer. Molecular Cancer Therapeutics 11 87-97. (doi:10.1158/1535-7163.MCT-11- 0540)
-
(2012)
Molecular Cancer Therapeutics
, vol.11
, pp. 87-97
-
-
Thomas, R.1
Sharifi, N.2
-
88
-
-
27644452640
-
Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer
-
doi:10.1158/1078-0432.CCR-05-0525
-
Titus MA, Schell MJ, Lih FB, Tomer KB & Mohler JL 2005 Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Clinical Cancer Research 11 4653-4657. (doi:10.1158/1078-0432.CCR-05-0525)
-
(2005)
Clinical Cancer Research
, vol.11
, pp. 4653-4657
-
-
Titus, M.A.1
Schell, M.J.2
Lih, F.B.3
Tomer, K.B.4
Mohler, J.L.5
-
89
-
-
67650071137
-
Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach?
-
doi:10.1038/nrd2803
-
Trachootham D, Alexandre J & Huang P 2009 Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nature Reviews Drug Discovery 8 579-591. (doi:10.1038/nrd2803)
-
(2009)
Nature Reviews Drug Discovery
, vol.8
, pp. 579-591
-
-
Trachootham, D.1
Alexandre, J.2
Huang, P.3
-
90
-
-
0037200046
-
p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression
-
doi:10.1074/jbc.M200266200
-
Uramoto H, Izumi H, Ise T, Tada M, Uchiumi T, Kuwano M, Yasumoto K, Funa K & Kohno K 2002 p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression. Journal of Biological Chemistry 277 31694-31702. (doi:10.1074/jbc.M200266200)
-
(2002)
Journal of Biological Chemistry
, vol.277
, pp. 31694-31702
-
-
Uramoto, H.1
Izumi, H.2
Ise, T.3
Tada, M.4
Uchiumi, T.5
Kuwano, M.6
Yasumoto, K.7
Funa, K.8
Kohno, K.9
-
91
-
-
33645514605
-
Inhibition of interleukin-6 with CNTO328, an antiinterleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice
-
doi:10.1158/0008-5472.CAN-05-3447
-
Wallner L, Dai J, Escara-Wilke J, Zhang J, Yao Z, Lu Y, Trikha M, Nemeth JA, Zaki MH & Keller ET 2006 Inhibition of interleukin-6 with CNTO328, an antiinterleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice. Cancer Research 66 3087-3095. (doi:10.1158/0008-5472.CAN-05-3447)
-
(2006)
Cancer Research
, vol.66
, pp. 3087-3095
-
-
Wallner, L.1
Dai, J.2
Escara-Wilke, J.3
Zhang, J.4
Yao, Z.5
Lu, Y.6
Trikha, M.7
Nemeth, J.A.8
Zaki, M.H.9
Keller, E.T.10
-
92
-
-
78049280194
-
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
-
doi:10.1073/pnas.1012443107
-
Watson PA, Chen YF, Balbas MD, Wongvipat J, Socci ND, Viale A, Kim K & Sawyers CL 2010 Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor. PNAS 107 16759-16765. (doi:10.1073/pnas.1012443107)
-
(2010)
PNAS
, vol.107
, pp. 16759-16765
-
-
Watson, P.A.1
Chen, Y.F.2
Balbas, M.D.3
Wongvipat, J.4
Socci, N.D.5
Viale, A.6
Kim, K.7
Sawyers, C.L.8
-
93
-
-
35948985191
-
The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy
-
doi:10.1677/ERC-07-0073
-
Wu CT, Chen WC, Liao SK, Hsu CL, Lee KD & Chen MF 2007 The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy. Endocrine-Related Cancer 14 633-643. (doi:10.1677/ERC-07-0073)
-
(2007)
Endocrine-Related Cancer
, vol.14
, pp. 633-643
-
-
Wu, C.T.1
Chen, W.C.2
Liao, S.K.3
Hsu, C.L.4
Lee, K.D.5
Chen, M.F.6
-
94
-
-
37149042709
-
ENaC a-subunit variants are expressed in lung epithelial cells and are suppressed by oxidative stress
-
doi:10.1152/ajplung.00248.2007
-
Xu H & Chu S 2007 ENaC a-subunit variants are expressed in lung epithelial cells and are suppressed by oxidative stress. American Journal of Physiology. Lung Cellular and Molecular Physiology 293 L1454-L1462. (doi:10.1152/ajplung.00248.2007)
-
(2007)
American Journal of Physiology. Lung Cellular and Molecular Physiology
, vol.293
-
-
Xu, H.1
Chu, S.2
-
95
-
-
25844486505
-
Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells
-
doi:10.1074/jbc.M504461200
-
Yang L, Xie S, Jamaluddin MS, Altuwaijri S, Ni J, Kim E, Chen YT, Hu YC, Wang L, Chuang KH et al. 2005 Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells. Journal of Biological Chemistry 280 33558-33565. (doi:10.1074/jbc.M504461200)
-
(2005)
Journal of Biological Chemistry
, vol.280
, pp. 33558-33565
-
-
Yang, L.1
Xie, S.2
Jamaluddin, M.S.3
Altuwaijri, S.4
Ni, J.5
Kim, E.6
Chen, Y.T.7
Hu, Y.C.8
Wang, L.9
Chuang, K.H.10
-
96
-
-
78751496139
-
Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells
-
doi:10.1002/pros.21243
-
Yokomizo A, Shiota M, Kashiwagi E, Kuroiwa K, Tatsugami K, Inokuchi J, Takeuchi A & Naito S 2011 Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells. Prostate 71 298-304. (doi:10.1002/pros.21243)
-
(2011)
Prostate
, vol.71
, pp. 298-304
-
-
Yokomizo, A.1
Shiota, M.2
Kashiwagi, E.3
Kuroiwa, K.4
Tatsugami, K.5
Inokuchi, J.6
Takeuchi, A.7
Naito, S.8
-
97
-
-
11244321598
-
Role of the BLT2, a leukotriene B4 receptor, in Ras transformation
-
doi:10.1038/sj.onc.1208151
-
Yoo MH, Song H, Woo CH, Kim H & Kim JH 2004 Role of the BLT2, a leukotriene B4 receptor, in Ras transformation. Oncogene 23 9259-9268. (doi:10.1038/sj.onc.1208151)
-
(2004)
Oncogene
, vol.23
, pp. 9259-9268
-
-
Yoo, M.H.1
Song, H.2
Woo, C.H.3
Kim, H.4
Kim, J.H.5
-
98
-
-
17844393395
-
Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells
-
doi:10.1093/carcin/bgi021
-
Yuan H, Gong A & Young CY 2005 Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells. Carcinogenesis 26 793-801. (doi:10.1093/carcin/bgi021)
-
(2005)
Carcinogenesis
, vol.26
, pp. 793-801
-
-
Yuan, H.1
Gong, A.2
Young, C.Y.3
-
99
-
-
0036170838
-
Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells
-
Zegarra-Moro OL, Schmidt LJ, Huang H & Tindall DJ 2002 Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Research 62 1008-1013. (Pubitemid 34160279)
-
(2002)
Cancer Research
, vol.62
, Issue.4
, pp. 1008-1013
-
-
Zegarra-Moro, O.L.1
Schmidt, L.J.2
Huang, H.3
Tindall, D.J.4
-
100
-
-
68449103870
-
NF-κB regulates androgen receptor expression and prostate cancer growth
-
doi:10.2353/ajpath.2009.080727
-
Zhang L, Altuwaijri S, Deng F, Chen L, Lal P, Bhanot UK, Korets R, Wenske S, Lilja HG, Chang C et al. 2009 NF-κB regulates androgen receptor expression and prostate cancer growth. American Journal of Pathology 175 489-499. (doi:10.2353/ajpath.2009.080727)
-
(2009)
American Journal of Pathology
, vol.175
, pp. 489-499
-
-
Zhang, L.1
Altuwaijri, S.2
Deng, F.3
Chen, L.4
Lal, P.5
Bhanot, U.K.6
Korets, R.7
Wenske, S.8
Lilja, H.G.9
Chang, C.10
-
101
-
-
84863857428
-
Mono-(2-ethylhexyl) phthalate affects the steroidogenesis in rat Leydig cells through provoking ROS perturbation
-
doi:10.1016/j.tiv.2012.04.003
-
Zhao Y, Ao H, Chen L, Sottas CM, Ge RS, Li L & Zhang Y 2012 Mono-(2-ethylhexyl) phthalate affects the steroidogenesis in rat Leydig cells through provoking ROS perturbation. Toxicology in Vitro 26 950-955. (doi:10.1016/j.tiv.2012.04.003)
-
(2012)
Toxicology in Vitro
, vol.26
, pp. 950-955
-
-
Zhao, Y.1
Ao, H.2
Chen, L.3
Sottas, C.M.4
Ge, R.S.5
Li, L.6
Zhang, Y.7
-
102
-
-
39449103998
-
TGF-b signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells
-
doi:10.1002/pros.20698
-
Zhu ML, Partin JV, Bruckheimer EM, Strup SE & Kyprianou N 2008 TGF-b signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Prostate 68 287-295. (doi:10.1002/pros.20698)
-
(2008)
Prostate
, vol.68
, pp. 287-295
-
-
Zhu, M.L.1
Partin, J.V.2
Bruckheimer, E.M.3
Strup, S.E.4
Kyprianou, N.5
-
103
-
-
0030811994
-
Androgen deprivation and radiation therapy: Sequencing studies using the Shionogi in vivo tumor system
-
doi:10.1016/S0360-3016(97)00309-X
-
Zietman AL, Prince EA, Nakfoor BM & Park JJ 1997 Androgen deprivation and radiation therapy: sequencing studies using the Shionogi in vivo tumor system. International Journal of Radiation Oncology, Biology, Physics 38 1067-1070. (doi:10.1016/S0360-3016(97)00309-X)
-
(1997)
International Journal of Radiation Oncology, Biology, Physics
, vol.38
, pp. 1067-1070
-
-
Zietman, A.L.1
Prince, E.A.2
Nakfoor, B.M.3
Park, J.J.4
|